Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment
Top Cited Papers
Open Access
- 1 June 2012
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 18 (6), 901-907
- https://doi.org/10.3201/eid1806.120116
Abstract
The era of iatrogenic Creutzfeldt-Jakob disease (CJD) has nearly closed; only occasional cases with exceptionally long incubation periods are still appearing. The principal sources of these outbreaks are contaminated growth hormone (226 cases) and dura mater grafts (228 cases) derived from human cadavers with undiagnosed CJD infections; a small number of additional cases are caused by neurosurgical instrument contamination, corneal grafts, gonadotrophic hormone, and secondary infection with variant CJD transmitted by transfusion of blood products. No new sources of disease have been identified, and current practices, which combine improved recognition of potentially infected persons with new disinfection methods for fragile surgical instruments and biological products, should continue to minimize the risk for iatrogenic disease until a blood screening test for the detection of preclinical infection is validated for human use.Keywords
This publication has 29 references indexed in Scilit:
- Candidate Cell Substrates, Vaccine Production, and Transmissible Spongiform EncephalopathiesEmerging Infectious Diseases, 2011
- Prion Disease Blood Test Using Immunoprecipitation and Improved Quaking-Induced ConversionmBio, 2011
- Prospective 10-year surveillance of human prion diseases in JapanBrain, 2010
- Dura mater graft‐associated Creutzfeldt‐Jakob disease in Japan: Clinicopathological and molecular characterization of the two distinct subtypesNeuropathology, 2009
- Risk behaviors in a rural community with a known point-source exposure to chronic wasting diseaseEnvironmental Health, 2008
- Iatrogenic Creutzfeldt Jakob disease 22 years after human growth hormone therapy: clinical and radiological featuresJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Prion removal by nanofiltration under different experimental conditionsBiologicals, 2008
- Clinical features and diagnosis of dura mater graft–associated Creutzfeldt–Jakob diseaseNeurology, 2007
- Novel methods for disinfection of prion-contaminated medical devicesThe Lancet, 2004
- Combination Ultrafiltration and 6 MUrea Treatment of Human Growth Hormone Effectively Minimizes Risk from Potential Creutzfeldt-Jakob Disease Virus ContaminationHormone Research, 1991